A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Ursula Wiedermann(Medical University of Vienna), Christoph Zielinski(Vienna General Hospital), Rupert Bartsch(Universitätszahnklinik Wien), Otto Scheiner(Medical University of Vienna), Rinaldo Zurbriggen, Joanna Jasińska(Medical University of Vienna), C Wiltschke(University of Vienna), G. Steger(Aristotle University of Thessaloniki), Michael Kundi(Medical University of Vienna), Hubert Pehamberger(Medical University of Vienna), Erika Garner‐Spitzer(Medical University of Vienna)
Cited by 120
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
|European Journal of Cancer|2016|579
Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.
|PubMed|2012|531
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496